CARsgen Therapeutics Holdings reports H1 results

1 hour ago 1

CARsgen Therapeutics Holdings press release (OTCPK:CRTHF): revenue was around RMB51 million for the six months ended June 30, 2025.
Gross profit was around RMB29 million for the six months ended June 30, 2025.
Cash and bank balances were around RMB1,261 million as of June 30, 2025. Cash and cash equivalents and deposits at the end of 2025 are expected to be not less than RMB1,100 million. The company expects to have adequate cash into the 2028 excluding subsequent cash inflows.

Recommended For You